Management of renal cell carcinoma with inferior vena cava tumor thrombus

Urologia Internationalis

Volumn 66, Issue 1, 2001, Pages 4-8

  Matsui, Yoshiyuki ^a   Fujikawa, Keita ^a   Oka, Hiroya ^a   Fukuzawa, Shigeki ^a   Takeuchi, Hideo ^a  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

C reactive protein; Inferior vena cava; Nephrectomy; Renal cell carcinoma; Tumor thrombus

Indexed keywords

ALPHA INTERFERON; C REACTIVE PROTEIN; GAMMA INTERFERON; TUMOR MARKER;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; FEMALE; HUMAN; INFERIOR CAVA VEIN; KIDNEY CARCINOMA; KIDNEY CELL; MALE; NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; THROMBECTOMY; TREATMENT OUTCOME; TUMOR THROMBUS;

ADULT; AGED; C-REACTIVE PROTEIN; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; PROBABILITY; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; THROMBECTOMY; THROMBOEMBOLISM; TREATMENT OUTCOME; VENA CAVA, INFERIOR;

EID: 0035170250     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056553     Document Type: Article

References (12)

1. Surgery for renal cell carcinoma in the vena cava
2. Extension of renal cell carcinoma into the vena cava: The rationale for aggressive surgical management
3. Diagnosis and management of renal carcinoma: A clinical and pathologic study of 309 cases
4. Renal cell carcinoma: Natural history and chemotherapeutic experience
5. Surgical management and prognosis of renal cell carcinoma invading the vena cava
6. Long-term followup after surgical treatment for renal cell carcinoma extending into the right atrium
7. Serum C-reactive protein level and the impact of cytoreductive surgery in patients with metastatic renal cell carcinoma
8. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: Long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy
9. Nephrectomy for metastatic renal cell carcinoma: A component of systemic treatment regimens
10. Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumor
11. Serum level of interleukin-6 as a prognosis factor in metastatic renal cell carcinoma